KALLEE HUMERICKHOUSE: Open Payments
NPI 1437796810 · SARASOTA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$503 in 23 payments from 12 companies in 2025. Trend: 2023 $1,661 · 2024 $991 · 2025 $503
Food & beverage: $503
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 4 | $81 |
| Lundbeck LLC | 2 | $76 |
| Alkermes, Inc. | 3 | $70 |
| Corium, LLC | 4 | $65 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $50 |
| Noven Therapeutics, LLC | 2 | $44 |
| E.R. Squibb & Sons, L.L.C. | 1 | $26 |
| Almatica Pharma LLC | 1 | $23 |
| Janssen Pharmaceuticals, Inc | 1 | $21 |
| Paratek Pharmaceuticals, Inc. | 1 | $17 |
Products named: REXULTI, Azstarys, TRINTELLIX, Xelstrym, ARISTADA, LYBALVI, COBENFY, LOREEV XR.
Industry payments across FL — which companies pay providers there.
